Search

Your search keyword '"Amatayakul-Chantler, Supavadee"' showing total 16 results
Start Over Author "Amatayakul-Chantler, Supavadee"
16 results on '"Amatayakul-Chantler, Supavadee"'

1. Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia

Author

Aggarwal, Anupriya, Stella, Alberto Ospina, Walker, Gregory, Akerman, Anouschka, Esneau, Camille, Milogiannakis, Vanessa, Burnett, Deborah L., McAllery, Samantha, Silva, Mariana Ruiz, Lu, Yonghui, Foster, Charles S. P., Brilot, Fabienne, Pillay, Aleha, Van Hal, Sabastiaan, Mathivanan, Vennila, Fichter, Christina, Kindinger, Andrea, Hoppe, Alexandra Carey, Munier, Mee Ling, Amatayakul-Chantler, Supavadee, Roth, Nathan, Coppola, Germano, Symonds, Geoff P., Schofield, Peter, Jackson, Jennifer, Lenthall, Helen, Henry, Jake Y., Mazigi, Ohan, Jäck, Hans-Martin, Davenport, Miles P., Darley, David R., Matthews, Gail V., Khoury, David S., Cromer, Deborah, Goodnow, Christopher C., Christ, Daniel, Robosa, Roselle, Starck, Damien J., Bartlett, Nathan W., Rawlinson, William D., Kelleher, Anthony D., and Turville, Stuart G.

Published
2022
Full Text
View/download PDF

2. Cross-Sectional and Longitudinal Genotype to Phenotype Surveillance of SARS-CoV-2 Variants Over the First Four Years of the COVID-19 Pandemic

Author

Akerman, Anouschka, primary, Fitcher, Christina, additional, Milogiannakis, Vanessa, additional, Esneu, Camille, additional, Ruiz Silva, Mariana, additional, Ison, Timothy, additional, Lopez, Joseph A., additional, Naing, Zin, additional, Caguicla, Joanna, additional, Amatayakul-Chantler, Supavadee, additional, Roth, Nathan, additional, Manni, Sandro, additional, Hauser, Thomas, additional, Barnes, Thomas, additional, Boss, Tino, additional, Condylios, Anna, additional, Yeang, Malinna, additional, Sato, Kenta, additional, Bartlett, Nathan Wylie, additional, Darley, David R., additional, Matthews, Gail, additional, Starck, Damian, additional, Promsri, Susan, additional, Rawlinson, William, additional, Murrel, Ben, additional, Kelleher, Anthony, additional, Dwyer, Dominic, additional, Sintchenko, Vitali, additional, Kok, Jen, additional, Ellis, Sally, additional, Marris, Kelsi, additional, Knight, Elizabeth, additional, Hoad, Veronica H., additional, Irving, David, additional, Gosbell, Ian, additional, Wood, James, additional, Brilot, Fabienne, additional, Aggarwal, Anupriya, additional, and Turville, Stuart, additional

Published
2024
Full Text
View/download PDF

3. Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level

Author

Akerman, Anouschka, primary, Milogiannakis, Vanessa, additional, Jean, Tyra, additional, Esneau, Camille, additional, Silva, Mariana Ruiz, additional, Ison, Timothy, additional, Fichter, Christina, additional, Lopez, Joseph A., additional, Chandra, Deborah, additional, Naing, Zin, additional, Caguicla, Joanna, additional, Li, Daiyang, additional, Walker, Gregory, additional, Amatayakul-Chantler, Supavadee, additional, Roth, Nathan, additional, Manni, Sandro, additional, Hauser, Thomas, additional, Barnes, Thomas, additional, Condylios, Anna, additional, Yeang, Malinna, additional, Wong, Maureen, additional, Foster, Charles S.P., additional, Sato, Kenta, additional, Lee, Sharon, additional, Song, Yang, additional, Mao, Lijun, additional, Sigmund, Allison, additional, Phu, Amy, additional, Vande More, Ann Marie, additional, Hunt, Stephanie, additional, Douglas, Mark, additional, Caterson, Ian, additional, Britton, Warwick, additional, Sandgren, Kerrie, additional, Bull, Rowena, additional, Lloyd, Andrew, additional, Triccas, Jamie, additional, Tangye, Stuart, additional, Bartlett, Nathan W., additional, Darley, David, additional, Matthews, Gail, additional, Stark, Damien J., additional, Petoumenos, Kathy, additional, Rawlinson, William D., additional, Murrell, Ben, additional, Brilot, Fabienne, additional, Cunningham, Anthony L., additional, Kelleher, Anthony D., additional, Aggarwal, Anupriya, additional, and Turville, Stuart G., additional

Published
2023
Full Text
View/download PDF

4. Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sublineages in the face of maturing antibody breadth at the population level

Author

Akerman, Anouschka, primary, Milogiannakis, Vanessa, additional, Jean, Tyra, additional, Esneau, Camille, additional, Silva, Mariana Ruiz, additional, Ison, Timothy, additional, Fitcher, Christina, additional, Lopez, Joseph A, additional, Chandra, Deborah, additional, Naing, Zin, additional, Caguicla, Joanna, additional, Li, Daiyang, additional, Walker, Gregory, additional, Amatayakul-Chantler, Supavadee, additional, Roth, Nathan, additional, Manni, Sandro, additional, Hauser, Thomas, additional, Barnes, Thomas, additional, Condylios, Anna, additional, Yeang, Malinna, additional, Wong, Maureen, additional, Foster, Charles S.P., additional, Sato, Kenta, additional, Lee, Sharon, additional, Song, Yang, additional, Mao, Lijun, additional, Sigmund, Allison, additional, Phu, Amy, additional, Vande More, Ann Marie, additional, Hunt, Stephanie, additional, Douglas, Mark, additional, Caterson, Ian, additional, Sandgren, Kerrie, additional, Bull, Rowena, additional, Lloyd, Andrew, additional, Triccas, Jamie, additional, Tangye, Stuart, additional, Bartlett, Nathan W, additional, Darley, David, additional, Matthews, Gail, additional, Stark, Damien J., additional, Rawlinson, William D., additional, Murrell, Ben, additional, Brilot, Fabienne, additional, Cunningham, Anthony L, additional, Kelleher, Anthony D., additional, Aggarwal, Anupriya, additional, and Turville, Stuart G., additional

Published
2022
Full Text
View/download PDF

5. SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern

Author

Aggarwal, Anupriya, primary, Akerman, Anouschka, additional, Milogiannakis, Vanessa, additional, Silva, Mariana Ruiz, additional, Walker, Gregory, additional, Stella, Alberto Ospina, additional, Kindinger, Andrea, additional, Angelovich, Thomas, additional, Waring, Emily, additional, Amatayakul-Chantler, Supavadee, additional, Roth, Nathan, additional, Manni, Sandro, additional, Hauser, Thomas, additional, Barnes, Thomas, additional, Condylios, Anna, additional, Yeang, Malinna, additional, Wong, Maureen, additional, Jean, Tyra, additional, Foster, Charles S.P., additional, Christ, Daniel, additional, Hoppe, Alexandra Carey, additional, Munier, Mee Ling, additional, Darley, David, additional, Churchill, Melissa, additional, Stark, Damien J., additional, Matthews, Gail, additional, Rawlinson, William D., additional, Kelleher, Anthony D., additional, and Turville, Stuart G., additional

Published
2022
Full Text
View/download PDF

6. SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern

Author

Aggarwal, Anupriya, primary, Stella, Alberto, additional, Walker, Gregory, additional, Akerman, Anouschka, additional, Milogiannakis, Vanessa, additional, Brilot, Fabienne, additional, Amatayakul-Chantler, Supavadee, additional, Roth, Nathan, additional, Coppola, Germano, additional, Schofield, Peter, additional, Jackson, Jennifer, additional, Lenthall, Helen, additional, Mazigi, Ohan, additional, Langley, David, additional, Lu, Yonghui, additional, Forster, Charles, additional, McAllery, Samantha, additional, Mathivanan, Vennila, additional, Fitcher, Christina, additional, Hoppe, Alexandra Carey, additional, Munier, C. Mee Ling, additional, Jack, Hans-Martin, additional, Cromer, Deborah, additional, Darley, David, additional, Matthews, Gail, additional, Christ, Daniel, additional, Khoury, David, additional, Davenport, Miles, additional, Rawlinson, William, additional, Kelleher, Anthony, additional, and Turville, Stuart, additional

Published
2022
Full Text
View/download PDF

7. Emergence and Antibody Evasion of BQ and BA.2.75 SARS-CoV-2 Sublineages in the Face of Maturing Antibody Breadth at the Population Level

Author

Akerman, Anouschka, primary, Milogiannakis, Vanessa, additional, Jean, Tyra, additional, Esneu, Camille, additional, Silva, Mariana Ruiz, additional, Ison, Timothy, additional, Fitcher, Christina, additional, Lopez, Joseph A., additional, Chandra, Deborah, additional, Naing, Zin, additional, Caguicla, Joanna, additional, Li, Daiyang, additional, Walker, Gregory, additional, Amatayakul-Chantler, Supavadee, additional, Roth, Nathan, additional, Manni, Sandro, additional, Hauser, Thomas, additional, Barnes, Thomas, additional, Condylios, Anna, additional, Yeang, Malinna, additional, Wong, Maureen, additional, Foster, Charles, additional, Lee, Sharon, additional, Song, Yang, additional, Mao, Lijun, additional, Sigmund, Allison, additional, Phu, Amy, additional, Vande More, Ann Marie, additional, Hunt, Stephanie, additional, Douglas, Mark, additional, Caterson, Ian, additional, Sandgren, Kerrie J., additional, Bull, Rowena Anne, additional, Lloyd, Andrew R., additional, Triccas, Jamie, additional, Tangye, Stuart G., additional, Bartlett, Nathan Wylie, additional, Darley, David R., additional, Matthews, Gail, additional, Starck, Damian, additional, Rawlinson, William, additional, Brilot, Fabienne, additional, Cunningham, Anthony L., additional, Kelleher, Anthony, additional, Aggarwal, Anupriya, additional, and Turville, Stuart, additional

Published
2022
Full Text
View/download PDF

8. SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern

Author

Aggarwal, Anupriya, primary, Stella, Alberto Ospina, additional, Walker, Gregory, additional, Akerman, Anouschka, additional, Milogiannakis, Vanessa, additional, Brilot, Fabienne, additional, Amatayakul-Chantler, Supavadee, additional, Roth, Nathan, additional, Coppola, Germano, additional, Schofield, Peter, additional, Jackson, Jennifer, additional, Henry, Jake Y., additional, Mazigi, Ohan, additional, Langley, David, additional, Lu, Yonghui, additional, Forster, Charles, additional, McAllery, Samantha, additional, Mathivanan, Vennila, additional, Fichter, Christina, additional, Hoppe, Alexandra Carey, additional, Munier, Mee Ling, additional, Jack, Hans-Martin, additional, Cromer, Deborah, additional, Darley, David, additional, Matthews, Gail, additional, Christ, Daniel, additional, Khoury, David, additional, Davenport, Miles, additional, Rawlinson, William, additional, Kelleher, Anthony D., additional, and Turville, Stuart, additional

Published
2021
Full Text
View/download PDF

11. Characterization of distinct functional domains of transforming growth factor beta

Author

Burmester, James K., Su Wen Qian, Roberts, Anita B., Huang, Alison, Amatayakul-Chantler, Supavadee, Suardet, Laurent, Odartchenko, Nicolas, Madri, Joseph A., and Sporn, Michael B.

Subjects
Transforming growth factors -- Research, Circular DNA -- Evaluation, Amino acid sequence -- Analysis, Science and technology
Abstract

The varying potencies of transforming growth factor (TGF) beta2 and TGF-beta1 on the fetal bovine heart endothelial cell development are due to aa 45 and 47 amino acids. TGF-beta1 and TGF-beta2 are the functional domains of TGF-beta, the former being sequestered by alpha2-macroglobulin. The activity of TGF-beta1 with aa 40-82 can be specified by amino acids external to the aa 40-82 region.

Published
1993

12. Heart and Liver Defects and Reduced Transforming Growth Factor β2 Sensitivity in Transforming Growth Factor β Type III Receptor-Deficient Embryos

Author

Stenvers, Kaye L., primary, Tursky, Melinda L., additional, Harder, Kenneth W., additional, Kountouri, Nicole, additional, Amatayakul-Chantler, Supavadee, additional, Grail, Dianne, additional, Small, Clayton, additional, Weinberg, Robert A., additional, Sizeland, Andrew M., additional, and Zhu, Hong-Jian, additional

Published
2003
Full Text
View/download PDF

16. Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos.

Author

Stenvers KL, Tursky ML, Harder KW, Kountouri N, Amatayakul-Chantler S, Grail D, Small C, Weinberg RA, Sizeland AM, and Zhu HJ

Subjects
Animals, Blotting, Northern, Blotting, Southern, Cell Nucleus metabolism, Dose-Response Relationship, Drug, Fibroblasts metabolism, Flow Cytometry, Genes, Reporter, Immunoblotting, Immunohistochemistry, Inhibitory Concentration 50, Ligands, Mice, Mice, Knockout, Microscopy, Fluorescence, Models, Genetic, Myocardium metabolism, Phenotype, RNA, Messenger metabolism, Recombination, Genetic, Reverse Transcriptase Polymerase Chain Reaction, Sensitivity and Specificity, Signal Transduction, Time Factors, Heart embryology, Liver embryology, Proteoglycans metabolism, Receptors, Transforming Growth Factor beta metabolism, Transforming Growth Factor beta genetics, Transforming Growth Factor beta metabolism
Abstract

The type III transforming growth factor beta (TGFbeta) receptor (TbetaRIII) binds both TGFbeta and inhibin with high affinity and modulates the association of these ligands with their signaling receptors. However, the significance of TbetaRIII signaling in vivo is not known. In this study, we have sought to determine the role of TbetaRIII during development. We identified the predominant expression sites of TbetaRIII mRNA as liver and heart during midgestation and have disrupted the murine TbetaRIII gene by homologous recombination. Beginning at embryonic day 13.5, mice with mutations in TbetaRIII developed lethal proliferative defects in heart and apoptosis in liver, indicating that TbetaRIII is required during murine somatic development. To assess the effects of the absence of TbetaRIII on the function of its ligands, primary fibroblasts were generated from TbetaRIII-null and wild-type embryos. Our results indicate that TbetaRIII deficiency differentially affects the activities of TGFbeta ligands. Notably, TbetaRIII-null cells exhibited significantly reduced sensitivity to TGFbeta2 in terms of growth inhibition, reporter gene activation, and Smad2 nuclear localization, effects not observed with other ligands. These data indicate that TbetaRIII is an important modulator of TGFbeta2 function in embryonic fibroblasts and that reduced sensitivity to TGFbeta2 may underlie aspects of the TbetaRIII mutant phenotype.

Published
2003
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results